Innoviva Inc (INVA):企業の財務・戦略的SWOT分析

◆英語タイトル:Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1682
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Innoviva Inc (INVA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Innoviva Inc (Innoviva) partners with companies that advance innovative therapies for improving patient care and building long-lasting value. Its operations are focused on royalty management. The company partners with GSK for the commercialization and development of respiratory products.The company’s current portfolio includes respiratory assets partnered with Glaxo Group Limited (GSK) for various respiratory disorders. It receives royalty payments on the sale of these partnered products to clients as per the terms of its agreements with GSK. Innoviva is headquartered in Brisbane, California, the US

Innoviva Inc Key Recent Developments

Feb 05,2020 Innoviva reports fourth quarter 2019 financial results
Oct 30,2019 Innoviva reports third quarter 2019 financial results
Jul 24,2019 Innoviva reports second quarter 2019 financial results
May 01,2019 Innoviva reports first quarter 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Innoviva Inc – Key Facts
Innoviva Inc – Key Employees
Innoviva Inc – Key Employee Biographies
Innoviva Inc – Major Products and Services
Innoviva Inc – History
Innoviva Inc – Company Statement
Innoviva Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Innoviva Inc – Business Description
R&D Overview
Innoviva Inc – Corporate Strategy
Innoviva Inc – SWOT Analysis
SWOT Analysis – Overview
Innoviva Inc – Strengths
Innoviva Inc – Weaknesses
Innoviva Inc – Opportunities
Innoviva Inc – Threats
Innoviva Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Innoviva Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 05, 2020: Innoviva reports fourth quarter 2019 financial results
Oct 30, 2019: Innoviva reports third quarter 2019 financial results
Jul 24, 2019: Innoviva reports second quarter 2019 financial results
May 01, 2019: Innoviva reports first quarter 2019 financial results
Feb 06, 2019: Innoviva reports fourth quarter 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Innoviva Inc, Key Facts
Innoviva Inc, Key Employees
Innoviva Inc, Key Employee Biographies
Innoviva Inc, Major Products and Services
Innoviva Inc, History
Innoviva Inc, Subsidiaries
Innoviva Inc, Key Competitors
Innoviva Inc, Ratios based on current share price
Innoviva Inc, Annual Ratios
Innoviva Inc, Annual Ratios (Cont...1)
Innoviva Inc, Annual Ratios (Cont...2)
Innoviva Inc, Interim Ratios
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Innoviva Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Innoviva Inc, Performance Chart (2015 - 2019)
Innoviva Inc, Ratio Charts
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Innoviva Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Innoviva Inc (INVA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pharmadax Inc (4191):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmadax Inc (Pharmadax) is a drug development and generic specialty pharmaceutical company. The company develops modified release generics in various therapeutic segments. It offers products such as glyburide, quetiapine fumarate ER and metoprolol succinate ER. Pharmadax provides in the pr …
  • Monotype Imaging Holdings Inc (TYPE):企業の財務・戦略的SWOT分析
    Summary Monotype Imaging Holdings Inc (Monotype Imaging) is a technology company, which offers text imaging solutions. The company’s products include embedded solutions and olapic earned content platform. Its solutions comprise imaging solutions for print, web and mobile environments. Monotype Imagi …
  • Bechtel Corporation:電力:M&Aディール及び事業提携情報
    Summary Bechtel Corporation (Bechtel) is a provider of engineering, construction and project management services. It provides a diverse portfolio of services to energy, transportation, infrastructure, communications, mining and metals, oil and gas, chemicals, water, defense and nuclear, and governme …
  • OTE Group:企業の戦略・SWOT・財務情報
    OTE Group - Strategy, SWOT and Corporate Finance Report Summary OTE Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • London North West Healthcare NHS Trust:企業の戦略的SWOT分析
    London North West Healthcare NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Humana Inc (HUM)-医療機器分野:企業M&A・提携分析
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • TRACOE medical GmbH:企業の戦略的SWOT分析
    TRACOE medical GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Stanwell Corp Ltd:企業の戦略的SWOT分析
    Stanwell Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Tianjin Chase Sun Pharmaceutical Co Ltd (300026):企業の財務・戦略的SWOT分析
    Summary Tianjin Chase Sun Pharmaceutical Co Ltd (Chase Sun) is a medicine and health industry group. The company research, develops, produces, and markets various pharmaceutical products. It offers products such as Chinese herb preparations, Chinese medicinal granules, synthetic drugs, biotech drugs …
  • Pental Limited (PTL):企業の財務・戦略的SWOT分析
    Pental Limited (PTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • United Overseas Bank Ltd:戦略・SWOT・企業財務分析
    United Overseas Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary United Overseas Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • McKesson Corp (MCK):医療機器:M&Aディール及び事業提携情報
    Summary McKesson Corp (McKesson) is a provider of healthcare services and information technology solutions. It distributes pharmaceuticals, medical equipment, and health and beauty care products in North America and overseas. The company also develops and provides decision support software and syste …
  • PT Soho Global Health Tbk (SOHO):企業の財務・戦略的SWOT分析
    PT Soho Global Health Tbk (SOHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Daily Mail and General Trust plc:企業のM&A・事業提携・投資動向
    Daily Mail and General Trust plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daily Mail and General Trust plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Tokyo Printing Ink Mfg Co Ltd (4635)
    Tokyo Printing Ink Mfg Co Ltd (4635) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Altana Ag:企業の戦略・SWOT・財務分析
    Altana Ag - Strategy, SWOT and Corporate Finance Report Summary Altana Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Taiwan Liposome Co Ltd (4152):企業の財務・戦略的SWOT分析
    Summary Taiwan Liposome Co Ltd (TLC) is a clinical-stage pharmaceutical company, which develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of adult …
  • Sumatec Resources Bhd (SUMATEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Sumatec Resources Bhd (Sumatec) is an oilfield service provider that offers of construction and drilling services to the oil and gas industry. The company’s services include engineering and construction for oil and gas facilities, oil and gas assets development, supply and management of onsh …
  • HeartWare International Inc-医療機器分野:企業M&A・提携分析
    Summary HeartWare International Inc (HeartWare), subsidiary of Medtronic Plc is a medical device company that develops and manufactures ventricular assist devices and implantable heart pumps for the treatment of advanced heart failure. The company provides HeartWare Ventricular Assist System that co …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆